Smile Invest

A dedicated investment team sources and proposes deals, but final approval rests with an investment committee that includes both the firm's professionals and the experienced entrepreneurs from its roughly 40 backing families. The board of directors — drawn from the same investor base — provides governance oversight.

Neither. It is an open-ended, evergreen investment company launched in 2017 and backed by roughly 40 entrepreneurial families. The permanent-capital structure avoids fixed fund lives, allowing it to hold assets indefinitely and recycle proceeds into new investments.

Smile Invest operates as one unified Benelux team from offices in Linden, Belgium and The Hague, Netherlands. Its primary sourcing advantage comes from the deep industrial networks of its family backers, who are active operators and board members across the region's manufacturing, technology, and food sectors.

Smile Invest focuses on direct equity investments — buyout, growth, and late-stage expansion — in Benelux-headquartered companies. While its strategy documents list secondaries as a capability, the core mandate is concentrated, active-ownership stakes rather than fund-of-funds commitments.

The firm's capital is pooled from roughly 40 entrepreneurial families in the Benelux. Named backers include Crop's Holding founder Michel Delbaere, Diepensteyn family office lead Bart Van Muylder, Soudal-linked Jurgen Vandervelden, and former Unilin/Mohawk executive Bernard Thiers.

The firm targets buyout, growth, late-stage expansion, and management buyout transactions. Its evergreen structure gives it flexibility to support companies through multiple expansion cycles rather than forcing a sale at the end of a fixed fund term.

Smile concentrates on four themes: advanced technology, healthcare innovation and wellness, environmental solutions and sustainability, and B2B services. The firm applies these themes to companies headquartered in the Benelux with ambitions to scale internationally.